Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1464 of 5804
-
Could a Parkinson's drug help treat a key symptom of depression?
Symptom relief CompletedThe heterogeneity of depression suggests that several different neurocircuits and pathophysiological mechanisms are involved. Anhedonia - the inability to experience pleasure from, or the lack of motivation to carry out, usually enjoyable activities - is a promising endophenotype…
Phase: PHASE3 • Sponsor: Region Skane • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New combo treatment aims to save hips from collapse
Disease control OngoingThe purpose of this study is to assess the clinical and x-ray results of patients who are treated with core decompression of the hip and the injection of a bone marrow concentrate and the use of the Bone Graft Substitute Genex®.
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can a steroid cocktail beat the standard nerve block for knee replacement pain?
Symptom relief Recruiting nowThe objective of this study is to investigate the efficacy of Dexamethasone sodium phosphate plus Methylprednisolone acetate in combination with plain bupivacaine ((B-DEX-MPA) compared with Liposomal Bupivacaine in combination with plain bupivacaine (B-LB) on post-surgical pain c…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New hope for Drug-Resistant epilepsy? phase 2 trial launches
Disease control Recruiting nowThis study will evaluate the safety and tolerability of SPN-817 in adults with treatment resistant seizures
Phase: PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug bulevirtide tracked in real-world hepatitis d patients
Disease control OngoingThe main goal of this study is to collect post marketing data from patients with chronic hepatitis D virus (HDV) infection who are treated with bulevirtide to describe the long-term effects of bulevirtide treatment and evaluate the safety of participants treated with bulevirtide.
Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New nasal spray vaccine for RSV shows promise in young children
⭐️ VACCINE ⭐️ CompletedThe primary purpose of the study is to assess the shedding, transmission, and genetic stability of the live-attenuated RSVt vaccine after each intranasal vaccination (56 days apart) in infants and toddlers 6 to \< 24 months of age.
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:14 UTC
-
New pill shows promise for Diabetes-Related vision loss
Disease control CompletedThe objective of this trial is to assess the safety, efficacy, and tolerability of RZ402 in patients with Diabetic Macular Edema.
Phase: PHASE2 • Sponsor: Rezolute • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Precision radiation boost aims to improve prostate cancer treatment
Disease control OngoingThis is a single-arm feasibility study that is recruiting 40 patients with histologically-proven localized prostate cancer and MRI-defined lesion(s). Participants in this study will get MR-guided radiotherapy boost to MRI visible tumour before or after whole gland radiation. Part…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Heart drug may keep AFib away after ablation in seniors
Disease control CompletedStudy name: Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation. Medicine: sacubitril/valsartan (100mg) and valsartan (80mg). Rationale: The latest guidelines represent an intensified …
Phase: PHASE4 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can Anti-Diarrhea meds make a powerful breast cancer drug safer?
Disease control CompletedThis is a multicenter, open-label, single-arm, multicohort, two-stage optimal Simon's design, phase II clinical trial that is designed to improve the tolerance of sacituzumab govitecan in patients with unresectable locally advanced or metastatic triple negative breast cancer (TNB…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New flu vaccine for toddlers shows promise in large trial
⭐️ VACCINE ⭐️ CompletedA random, blind and positive control design was adopted.the investigators will assess the safety and immunogenicity of 2 doses of an quadrivalent influenza vaccine virus subunit in children aged 6 to 35 months. A total of 2,772 subjects in the 6-35 month age group were randomly …
Phase: PHASE3 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:08 UTC
-
New hope for rare eye disease: personalized drug schedule shows promise
Disease control CompletedThis study is a 60-week, two-arm, randomized, open-label, active-controlled, multi-center study in patients with Polypoidal choroidal vasculopathy (PCV) who have not previously received anti-Vascular endothelial growth factor (VEGF) treatment.
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New pill targets rare genetic cancers in first human trial
Disease control OngoingThis is a Phase 1/1b, open-label, first-in-human (FIH) study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary antineoplastic activity of APS03118 administered orally in participants with RET-altered solid tumors.
Phase: PHASE1 • Sponsor: Applied Pharmaceutical Science, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Breath sniffing may reveal early clues to cystic fibrosis drug success
Knowledge-focused CompletedThis study relies on the hypotheses that (1) exhaled breath is intimately correlated to the patient's lung condition and that (2)the composition of exhaled breath , i.e. the VOCs profile, will be significantly modified from the first days of treatment by CFTR modulators in a or p…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New hope for failed Weight-Loss surgery: simpler bypass shows promise
Disease control Recruiting nowSleeve gastrectomy (SG) has become the most commonly performed weight loss surgery, accounting for 60% of all bariatric operations worldwide. While technically easier with less side-effects and nutritional risks than other operations, SG is also associated with a higher risk of f…
Phase: NA • Sponsor: Laval University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Could a salad ingredient help treat diabetes? new trial underway
Disease control Recruiting nowBlood sugar levels are controlled by insulin, a hormone made by cells in the pancreas. After a meal, carbohydrates are broken down into glucose which is absorbed from the intestine into the blood leading to a rise in glucose (blood sugar) which triggers the secretion of insulin. …
Phase: PHASE2 • Sponsor: Housey Healthcare ULC • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart failure drug may ease tissue congestion without harming blood flow
Disease control CompletedThe overall hypothesis is that treatment with the SGLT2 inhibitor Ertugliflozin induces a differential regulation in interstitial fluid vs plasma volume, with more reduction of the volume from the interstitial fluid than from the circulating plasma volume, which results in Ertugl…
Phase: PHASE4 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Precision radiation may cut side effects in cervical cancer
Disease control OngoingOnline adaptive radiotherapy (oART) has demonstrated to be feasible to reduce planning target volume (PTV) margins for cervical cancer. To explore the value of reduced margins in oART for cervical cancer, we conducted a prospective clinical trial to determine the clinical efficac…
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Experimental virus vaccine takes on multiple cancers in early trial
Disease control Recruiting nowThis study is being conducted to explore the immunological mechanism of action of Peptide-coated Conditionally Replicating Adenovirus-1 (PeptiCRAd-1) plus Checkpoint inhibitor (CPI) therapy in multiple cancer types, as well as to obtain early information on the safety of this com…
Phase: PHASE1 • Sponsor: Valo Therapeutics Oy • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Breathing battle: which oxygen method saves more lives after ICU extubation?
Disease control Recruiting nowIn intensive care units (ICUs), around 20% of patients experience respiratory failure after planned extubation. Nearly 40-50% of them eventually require reintubation with subsequently high mortality rates reaching 30-40%. NIV used as rescue therapy to treat post-extubation respir…
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC